Methods for treating vasomotor symptoms in castrated prostatic cancer patients with low dose cyproterone acetate

Details for Australian Patent Application No. 2009303272 (hide)

Owner Teva Women's Health, Inc.

Inventors Ahmed, Salah U.; Sethia, Sundeep; Reape, Kathleen; Hait, Howard; BenMaimon, Carole S.

Agent Spruson & Ferguson

Pub. Number AU-A-2009303272

PCT Pub. Number WO2010/042930

Priority 61/136,893 10.10.08 US

Filing date 12 October 2009

Wipo publication date 15 April 2010

International Classifications

A61K 31/56 (2006.01) - Compounds containing cyclopenta[a]hydrophenanthrene ring systems

A61K 31/21 (2006.01) - Esters, e.g. nitroglycerine, selenocyanates

Event Publications

26 May 2011 Amendment Made

  The nature of the amendment is: Amend the name of the inventor to read Ahmed, Salah U.; Sethia, Sundeep; Reape, Kathleen; Hait, Howard and Ben-Maimon, Carole S.

2 June 2011 PCT application entered the National Phase

  PCT publication WO2010/042930 Priority application(s): WO2010/042930

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009303284-Biochemically stabilized HIV-1 env trimer vaccine

2009303261-Energy generating system